Invention Grant
- Patent Title: Drug-eluting intravascular prostheses and methods of use
- Patent Title (中): 药物洗脱血管内假体和使用方法
-
Application No.: US12455521Application Date: 2009-06-02
-
Publication No.: US08088160B2Publication Date: 2012-01-03
- Inventor: Moshe Flugelman
- Applicant: Moshe Flugelman
- Applicant Address: IL Haifa
- Assignee: Multi-Gene Vascular Systems Ltd. (“MGVS”)
- Current Assignee: Multi-Gene Vascular Systems Ltd. (“MGVS”)
- Current Assignee Address: IL Haifa
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Agent Ivor R. Elrifi; Matthew Pavao
- Main IPC: A61F2/06
- IPC: A61F2/06

Abstract:
The present invention provides intravascular prostheses and methods of production and use. An implantable device for treating a vascular disease or disorder includes an intravascular prosthesis containing an inhibitor of smooth muscle cell proliferation and a growth factor. The device can be coated with a biodegradable drug-eluting polymer that is impregnated with the inhibitor of smooth muscle cell proliferation and the growth factor. The device is useful for treating or preventing a vascular disease or disorder such as restenosis, by simultaneously inhibiting vessel blockage and enhancing recovery of the vessel wall following an intravascular intervention.
Public/Granted literature
- US20090263452A1 Drug-eluting intravascular prostheses and methods of use Public/Granted day:2009-10-22
Information query
IPC分类: